PubRank

Abdissa Negassa

Author PubWeight™ 48.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003 15.06
2 Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003 2.10
3 Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst 2008 1.72
4 Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes? Am Heart J 2002 1.64
5 Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2002 1.48
6 Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 2012 1.39
7 A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 2010 1.35
8 Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2010 1.20
9 Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Eur Heart J 2005 1.13
10 Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med 2010 1.09
11 Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Clin Cancer Res 2009 1.00
12 Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol 2012 0.98
13 A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat 2008 0.95
14 Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR. J Biol Chem 2013 0.93
15 Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008 0.93
16 Radiofrequency ablation of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2011 0.92
17 The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. Cancer Res 2003 0.91
18 Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study. J Heart Lung Transplant 2013 0.90
19 Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system. J Invasive Cardiol 2007 0.89
20 Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev 2008 0.86
21 Phase I trial of metronomic oral vinorelbine in patients with advanced cancer. Cancer Chemother Pharmacol 2011 0.83
22 High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer. J Acquir Immune Defic Syndr 2012 0.83
23 Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. Eur J Heart Fail 2007 0.83
24 Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila) 2008 0.83
25 Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. Am J Epidemiol 2003 0.83
26 The Mayo Clinic Risk Score predicts in-hospital mortality following primary angioplasty. J Invasive Cardiol 2005 0.82
27 Investigation of the urge-to-cough sensation in healthy volunteers. Respirology 2012 0.82
28 Access to revascularization among patients with acute myocardial infarction in New York City--impact of hospital resources. J Urban Health 2006 0.80
29 Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study. Cancer Epidemiol 2010 0.80
30 Mortality and readmission rates in patients hospitalized for acute decompensated heart failure: a comparison between cardiology and general-medicine service outcomes in an underserved population. Clin Cardiol 2015 0.79
31 Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma. Med Oncol 2005 0.78
32 A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Res Treat 2014 0.78
33 Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma. Lab Invest 2007 0.78
34 A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk. J Oncol 2011 0.78
35 Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer. Clin Breast Cancer 2004 0.77
36 MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL. Endocr Pract 2015 0.75
37 Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma. Am J Clin Oncol 2003 0.75
38 Effectiveness of glycoprotein IIb/IIIa inhibitor use during primary coronary angioplasty: results of propensity analysis using the New York State Percutaneous Coronary Intervention Reporting System. Am J Cardiol 2006 0.75